MIAMI--(BUSINESS WIRE)--DermaSensor Inc. – Skin cancer is a global health concern, with increasing incidence rates worldwide. Artificial Intelligence (AI) is expanding its presence within dermatology ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

Please provide your email address to receive an email when new articles are posted on . The device achieved an overall sensitivity of 97.04%. The device had an overall specificity of 26.22%, a ...

Data published in the Journal of the American Board of Family Medicine shows that DermaSensor’s elastic scattering spectroscopy device improves primary care clinicians’ ability to assess skin lesions ...

Dermasensor Inc.’s elastic scattering spectroscopy device appears to have solved one of the more challenging issues in dermatology—early detection of skin cancers in individuals with darker skin tones ...